Listed

Mesoblast Ltd: Form 20-F for the period ended Jun 30, 2025

Filed with the SEC on Aug 29, 2025 and accepted by EDGAR at Aug 29, 2025, 06:22 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2024-07-01 to 2025-06-30$17.2mifrs-full:Revenue
Cost of revenue12 months2024-07-01 to 2025-06-30$5.1mifrs-full:CostOfSales
Income tax12 months2024-07-01 to 2025-06-30$330.0kifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2024-07-01 to 2025-06-30−$102.1mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2024-07-01 to 2025-06-30−$0.08ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2024-07-01 to 2025-06-30−$0.08ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2024-07-01 to 2025-06-30−$50.0mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2024-07-01 to 2025-06-30$680.0kifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2025-06-30$161.6mifrs-full:CashAndCashEquivalents
Current assetsAt period end2025-06-30$204.3mifrs-full:CurrentAssets
Total assetsAt period end2025-06-30$784.7mifrs-full:Assets
Current liabilitiesAt period end2025-06-30$102.6mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2025-06-30$187.2mifrs-full:Liabilities
Shareholders' equityAt period end2025-06-30$597.4mifrs-full:Equity
Shares outstandingAt period end2025-06-301,279,967,187 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001345099-25-000067. Last ingested by Listed: Oct 29, 2026, 06:58 ET. Listed shows no prices and gives no investment advice.